Elotuzumab (Empliciti)

Elotuzumab (sold under the brand name Empliciti) is a targeted medication used to treat multiple myeloma. It is a monoclonal antibody, which is a lab-made protein designed to locate a specific marker on the surface of myeloma cells and certain immune cells. By attaching to this marker, elotuzumab helps your body's natural immune system identify and remove the cancer cells. In this community, you can learn how this medication is given, discuss potential side effects, and connect with other patients and caregivers about what to expect during treatment.